medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2018, Number 2

<< Back Next >>

Cir Card Mex 2018; 3 (2)

TAVI transapical: “Manejo multidisciplinario en octogenarios”

Zúniga-Alaniz LM, Hernández-Rendón E, Pérez-Rubio NA, Uribe J, Riera-Kinkel C

Language: Spanish
References: 8
Page: 54-56
PDF size: 157.47 Kb.


ABSTRACT

The octogenarian patients with multiple comorbidities and with high surgical risk, who require aortic valve replacement, who can not undergo conventional surgery or percutaneous TAVI, the implantation of transapical TAVI seems to be an adequate option with very good outcome in our institution. No mortality is reported here in our 4 cases series at 2-year follow-up.


REFERENCES

  1. Arsalan M, Szerlip M, Vemulapalli S, Holper EM, Arnold SV, Li Z, et al. Shouldtranscatheter aortic valve replacement be performed in nonagenarians?: Insightsfrom the STS/ACC TVT Registry. J Am Coll Cardiol 2016;67:1387-95.

  2. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V,et al. Transcatheter aortic valve replacement versus surgical valve replacement inintermediate-risk patients: a propensity score analysis. Lancet 2016;387:2218-25.

  3. Rosa VE, Lopes AS, Accorsi TA, Fernandes JR, Spina GS, Sampaio RO, et al.EuroSCORE II and STS as mortality predictors in patients undergoing TAVI. RevAssoc Med Bras 2016;62:32-7.

  4. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantationof an aortic valve prosthesis for calcific aortic stenosis: first human case description.Circulation 2002;106:3006-8.

  5. Mieres J, Menéndez M, Fernández-Pereira C, Rubio M, Rodríguez AE. Transapicalimplantation of a 2nd-generation JenaValve device in patient with extremelyhigh surgical risk. Case Rep Cardiol 2015;2015:458151.

  6. Volodarsky I, Shimoni S, George J. The current status of transcutaneous aorticvalve implantation. Expert Rev Cardiovasc Ther 2014; 12: 1205-18.

  7. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Updateof the 2014 AHA/ACC Guideline for the Management of Patients With ValvularHeart Disease: A Report of the American College of Cardiology/American HeartAssociation Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;70: 252-89.

  8. Özkan M. What is new in ACC/AHA 2017 focused update of valvular heart diseaseguidelines. Anatol J Cardiol 2017; 17: 421-2.




2020     |     www.medigraphic.com